The heartburn drug Kapidex was approved for use in the United States in January 2009 for patients suffering from gastroesophageal reflux disease and has become very popular. However, according to the Food and Drug Administration (FDA), pharmacists are frequently confusing Kapidex with the prostate cancer drug Casodex and the narcotic pain reliever Kadian.
For this reason starting next month Kapidex will be renamed and called Dexilant. The FDA said that they have no other problems with the drug other than the confusion caused by its name. bjmdjd
Material modifications since posting: none
Comments
To add a comment to the original post, click here.
You must be signed in to post a comment.
Sign in nowThere are no comments for this post.